Vertical: CNMBase Year: 2025
Market Size (2025)
$1.27B
Projected (2032)
$2.36B
CAGR (2022–2032)
9.3%
Key Players
9+
Market Overview
The Global Vitamin-Based Biostimulants Market was valued at USD 1,272.18 million in 2025 and is projected to reach USD 2,361.55 million by 2032, expanding at a CAGR of 9.22% during 2026–2032. Over the historic period the market increased from USD 972.04 million in 2022 to USD 1,163.33 million in 2024, and the forecast period adds an absolute USD 1,089.36 million between 2025 and 2032, almost doubling the 2025 market size.
Vitamin-based biostimulants are formulations in which vitamins such as thiamine (B1), riboflavin (B2), folic acid (B9), ascorbic acid (vitamin C) and tocopherols (vitamin E) act as functional components, usually in combination with amino acids, betaines, seaweed or plant extracts and micronutrients. They are applied to foliage, soil, fertigation systems or seed to support plant metabolism, antioxidant capacity and tolerance to abiotic stress, and to improve nutrient-use efficiency and crop quality. Demand is supported by the rising frequency of heat, drought and salinity stress, the formal recognition of plant biostimulants in fertiliser legislation in the European Union, India and Brazil, and growers' need to protect yield and quality in high-value fruit and vegetable production.
Key Findings
Physical Form: Liquid is the largest segment with 70.0% of the market in 2025 (USD 890.53 million) and is also the fastest-growing segment, at a CAGR of 9.74%.
Crop Type: Fruits & Vegetables is the largest segment with a 55.0% share in 2025 (USD 699.70 million), while Cereals & Grains is the fastest-growing segment, at a CAGR of 10.41%.
Application Method: Foliar application leads with a 70.0% share in 2025 (USD 890.53 million); the Others segment grows fastest, at a CAGR of 10.10%.
Region: Europe is the leading region with 37.0% of global revenue in 2025 (USD 470.71 million), while Asia Pacific is the fastest-growing region, at a CAGR of 10.68%.
Country: U.S. is the largest country market, valued at USD 195.92 million in 2025, and India is the fastest-growing country, at a CAGR of 13.02%.
Segmentation Summary
By physical form, liquid formulations accounted for USD 890.53 million in 2025 against USD 381.65 million for dry formulations. Liquid products dominate because vitamins, amino acids and plant extracts are easier to stabilise, tank-mix and dose in solution, and because foliar spraying and fertigation are the main delivery routes. Liquid products are projected to grow at 9.74% against 7.96% for dry products.
By crop type, Fruits & Vegetables generated USD 699.70 million in 2025, reflecting the high value per hectare of horticultural crops and growers' focus on fruit set, size, colour and shelf life. Cereals & Grains (USD 318.05 million in 2025) is the fastest-growing crop segment at 10.41%, as stress-mitigation products are increasingly used on broadacre crops, and the Others segment, valued at USD 254.44 million, grows at 9.59%.
By application method, foliar application represented USD 890.53 million in 2025 and grows at 8.83%, while the Others segment, which covers soil, fertigation and seed-applied use, grows faster at 10.10%, reaching USD 748.61 million in 2032.
Regionally, Europe (USD 470.71 million in 2025) remains the largest market, supported by its established biostimulant industry and the EU Fertilising Products Regulation. Asia Pacific (USD 279.88 million) is the second-largest region and the fastest-growing at 10.68%, followed by Latin America at 10.52% and Middle East & Africa at 10.41%. North America, valued at USD 254.44 million in 2025, grows at 8.33%.
Competitive Landscape Summary
The market is moderately fragmented. Large agricultural input groups that built biologicals platforms through acquisitions, notably Syngenta Group (Syngenta Biologicals, which incorporates Valagro), Corteva Agriscience (Stoller and Symborg), UPL (Natural Plant Protection) and Rovensa (Rovensa Next), compete alongside specialist formulators such as Biolchim (J.M. Huber Corporation), Haifa Group, Atlántica Agrícola, Gowan Company (Isagro) and OMEX. Products that declare vitamin content include Valagro's MEGAFOL, Biolchim's FOLICIST (folic acid), HaifaStim Promo (folic acid), Atlántica Agrícola's Razormin (vitamin complexes), Tradecorp's Biimore and OMEX's StimPro-K (vitamin B1 and vitamin C). Competition centres on proven field efficacy, regulatory registrations in each market, formulation know-how and access to distribution channels. Since 2022 the industry has seen significant consolidation, including Corteva's acquisitions of Stoller and Symborg, J.M. Huber's acquisition of the Biolchim Group and Rovensa's acquisition of Cosmocel.
Challenges and Opportunities
The main challenges are inconsistent field performance across crops, climates and application timings; fragmented and evolving registration requirements, ranging from CE-marking under Regulation (EU) 2019/1009 to Schedule VI notification under India's Fertiliser (Control) Order; the stability of vitamins, which degrade with heat, light and unsuitable pH; and the dependence of vitamin supply on a concentrated group of producers. Opportunities arise from the formalisation of the Indian biostimulant market, Brazil's Bioinputs Law (Law No. 15.070 of 2024), the use of stress-mitigation products on cereals and other broadacre crops, and integration of vitamin-based products into fertigation programmes in protected cultivation in the Middle East, Asia and Latin America.
Future Outlook
The market is expected to grow every year of the forecast period, from USD 1,390.86 million in 2026 to USD 2,361.55 million in 2032. Growth will be led by liquid formulations, cereal and grain applications and emerging regions, with Asia Pacific increasing from USD 279.88 million in 2025 to USD 571.49 million in 2032 and Latin America from USD 203.55 million to USD 410.91 million. Clearer claim standards (the EN 17700 series developed by CEN/TC 455), the outcome of US federal biostimulant legislation and continued investment by large crop-input groups in biologicals are expected to shape product development, with suppliers favouring multi-component formulations that combine vitamins with amino acids, seaweed extracts and fermentation-derived ingredients.
The Vitamin-Based Biostimulants Market market is projected to grow at a CAGR of 9.3% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
A plant biostimulant is a product that stimulates plant nutrition processes independently of its nutrient content, with the aim of improving nutrient-use efficiency, tolerance to abiotic stress, quality traits or the availability of nutrients confined in the soil or rhizosphere. This is the definition used in Regulation (EU) 2019/1009. Vitamin-based biostimulants are the subset of these products in which one or more vitamins are a declared, functional constituent of the formulation.
Vitamins act in plants as enzyme cofactors and antioxidants. Thiamine (B1) is a cofactor in carbohydrate and energy metabolism, folic acid (B9) takes part in one-carbon metabolism, ascorbic acid (vitamin C) is a principal scavenger of reactive oxygen species, and tocopherols (vitamin E) protect cell membranes against lipid peroxidation. When applied to plants, often together with amino acids, glycine betaine, proline, seaweed extracts or plant extracts, these compounds are used to help crops withstand heat, drought, salinity and transplant stress and to support flowering, fruit set and quality.
Included in the scope: liquid and dry biostimulant formulations that declare vitamin content, whether vitamins are the main active or are combined with amino acids, betaines, seaweed or plant extracts and micronutrients; products applied by foliar spray, soil application, fertigation or seed treatment; and use on all crop types.
Excluded from the scope: straight fertilisers whose claims rest only on nutrient content; plant protection products and plant growth regulators registered as pesticides; biostimulants with no declared vitamin component (for example, pure humic substances, pure seaweed extracts or microbial inoculants); and vitamins sold for human nutrition, animal feed or pharmaceutical use.
Scope of the Study
The study covers the Global Vitamin-Based Biostimulants Market and analyses it by the following segmentations:
By Physical Form: Liquid, Dry
By Crop Type: Fruits & Vegetables, Cereals & Grains, Others
By Application Method: Foliar, Others
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, with country-level analysis within each region
Historic data is presented for 2022, 2023 and 2024, 2025 is the base year, and the forecast period is 2026–2032. Growth rates are expressed as the compound annual growth rate (CAGR) for 2026–2032. All market values are in USD Million.
Research Objectives
To estimate the size of the global vitamin-based biostimulants market for 2022–2025 and forecast it for 2026–2032 in USD Million.
To analyse the market by physical form, crop type and application method, and to identify the largest and fastest-growing segments.
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges that influence the adoption of vitamin-based biostimulants.
To examine the regulatory frameworks that govern the registration, labelling and marketing of biostimulants in major regions.
To analyse the value chain from vitamin and co-ingredient supply through formulation and distribution to growers.
To profile the competitive environment, including the positioning of leading companies and key developments since 2022.
To assess the competitive forces and the macro-environmental (PESTEL) factors affecting the industry.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured process combining secondary research, primary research and analytical modelling. The process began with defining the product scope and segmentation, followed by collecting data on biostimulant consumption, crop areas, fertiliser and specialty-input use, product registrations and company activity. Market estimates were developed using top-down and bottom-up approaches, validated through primary interviews with industry participants and triangulated to arrive at final values for each segment, region and country.
Step 1 – Scope definition: definition of vitamin-based biostimulants, inclusions and exclusions, and segmentation.
Step 2 – Secondary research: collection of industry, regulatory, trade and company data.
Step 3 – Primary research: discussions with supply-side and demand-side participants to validate assumptions.
Step 4 – Market estimation: top-down and bottom-up sizing, followed by data triangulation.
Step 5 – Forecasting: projection of each segment for 2026–2032 based on demand drivers and constraints.
Step 6 – Validation and reporting: consistency checks across segments, regions and countries.
Secondary Research
Secondary research drew on sources relevant to the biostimulant and specialty plant nutrition industry, including:
Industry associations: European Biostimulants Industry Council (EBIC), Biological Products Industry Alliance (BPIA) in the United States, the Association of American Plant Food Control Officials (AAPFCO), the International Fertilizer Association (IFA) and national biostimulant and bio-input associations in India and Brazil.
Government and regulatory bodies: the European Commission and EUR-Lex (Regulation (EU) 2019/1009), the US Environmental Protection Agency and US Department of Agriculture, the Canadian Food Inspection Agency, India's Department of Agriculture & Farmers Welfare, Brazil's Ministry of Agriculture and Livestock (MAPA), Japan's Ministry of Agriculture, Forestry and Fisheries and China's Ministry of Agriculture and Rural Affairs.
Company filings: annual reports, financial results, investor presentations and press releases of crop-input companies, together with product labels and technical data sheets that declare vitamin content.
Trade journals and publications: specialist agricultural input publications such as New AG International and AgroPages, horticulture trade media, and peer-reviewed research on the effects of exogenous vitamins on crop stress tolerance.
Paid databases: company information, trade and agricultural statistics databases used to analyse crop areas, fertiliser consumption and company financials.
Primary Research
Primary research was carried out through in-depth interviews and structured discussions with participants across the value chain. The objectives were to validate market size and segment splits, understand pricing and product mix, assess adoption by crop and region, and test assumptions on growth drivers and constraints.
Supply side: executives and product managers at biostimulant manufacturers and formulators, suppliers of vitamins, amino acids and botanical extracts, regulatory affairs specialists and contract manufacturers.
Demand side: distributors and agri-input retailers, agronomists and crop advisers, large commercial growers of fruits, vegetables and field crops, greenhouse operators and farmer cooperatives.
Other experts: researchers at agricultural universities and research institutes working on plant stress physiology and biostimulant efficacy.
Market Size Estimation
Top-down approach: the overall agricultural biostimulants market was used as the starting point, and the share attributable to vitamin-containing formulations was estimated from product portfolio analysis, company revenues and industry interviews. This value was then allocated to regions, countries and segments based on crop area, specialty crop production and the penetration of biostimulants in each geography.
Bottom-up approach: country-level consumption was estimated by combining the treated area of each crop group with typical application rates, number of applications per season and average selling prices for liquid and dry products. Country estimates were aggregated to regional and global totals.
Data triangulation: the results of both approaches were compared and reconciled with supply-side revenue estimates and primary interview inputs. Differences were resolved by revisiting the underlying assumptions, and final values were checked for consistency so that segment, country and regional values sum to the corresponding totals.
Forecasting Methodology
Forecasts for 2026–2032 were developed for each segment and geography by projecting the base-year value using growth rates derived from demand-side and supply-side factors. The factors considered include:
Growth in fruit, vegetable and cereal production and the area under protected cultivation and fertigation.
Frequency and severity of heat, drought and salinity stress events affecting crop yields.
Regulatory developments, including the implementation of biostimulant frameworks in the EU, India, Brazil and the United States.
Fertiliser prices and the emphasis on nutrient-use efficiency.
Product launches, capacity investments and distribution expansion by leading companies.
Farm income and agricultural commodity price cycles that influence spending on specialty inputs.
Each factor was assessed for its impact over the short term (2026–2027), medium term (2028–2030) and long term (2031–2032), and the resulting growth paths were reviewed with industry participants.
Assumptions and Limitations
Market values are expressed in nominal USD; local-currency revenues are converted at average annual exchange rates, and exchange-rate movements are not forecast separately.
The forecast assumes no major disruption to vitamin and co-ingredient supply chains and no regulatory decision that removes vitamin-based biostimulants from any major market.
Biostimulant regulations are still evolving in several countries; the forecasts assume implementation of current frameworks as announced.
Because many companies do not disclose revenues for biostimulants, and fewer still for vitamin-containing products, company-level estimates rely on triangulation and may be less precise than market-level values.
Vitamin-based biostimulants are frequently multi-component products; the market boundary is defined by declared vitamin content, and products with undisclosed compositions are classified based on available label and technical information.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global vitamin-based biostimulants market is moderately fragmented. A group of large agricultural input companies with global distribution networks competes with specialist biostimulant and specialty-fertiliser formulators and a long tail of regional and local companies, particularly in India, China, Latin America and Southern Europe. No single company dominates, and vitamin-containing products typically form part of broader biostimulant portfolios rather than standalone businesses.
Competition is based on demonstrated field efficacy, formulation quality and stability, the breadth of registrations across countries, technical support to growers and distributors, and price. Since 2022 the market has consolidated as crop-protection and specialty-materials groups acquired biostimulant specialists, while specialists have expanded through new subsidiaries, distribution agreements and investment in fermentation and production capacity. Regulatory changes in the EU, India and Brazil are raising the cost of compliance and are expected to favour companies with strong regulatory and research capabilities.
Key Player Positioning
Leaders. Syngenta Group, Corteva Agriscience, UPL and Rovensa have the broadest biostimulant portfolios and the widest geographic reach. Syngenta Group, which reported 2025 sales of USD 28.4 billion, combined Valagro and its in-house biologicals into Syngenta Biologicals in 2023; Valagro's MEGAFOL is marketed as containing vitamins, amino acids, proteins and betaines. Corteva, with 2025 net sales of USD 17.40 billion, built Corteva Biologicals through the 2023 acquisitions of Stoller and Symborg, and competes with plant-hormone-based, microbial and nutrient-use-efficiency biostimulants for the same stress-mitigation and yield applications. UPL, which reported consolidated revenue of INR 51,839 crore for the year ended March 2026, operates its biosolutions business through Natural Plant Protection (NPP) and has expanded through partnerships and investments. Rovensa, through its Rovensa Next biosolutions unit (including Tradecorp, Idai Nature and Cosmocel), offers Biimore, a fermentation-derived biostimulant containing amino acids and vitamins.
Challengers. Biolchim (part of J.M. Huber Corporation's Huber AgroSolutions since 2022), Haifa Group and Gowan Company (which acquired Isagro in 2021) have established biostimulant ranges with products that declare vitamin content, such as Biolchim's FOLICIST (with folic acid), HaifaStim Promo (with 1% folic acid) and Isagro's Ergostim (folic acid with folcisteine). These companies have strong positions in specific crops or regions and leverage specialty fertiliser or crop protection channels.
Niche players. Atlántica Agrícola, which reported sales of EUR 47.6 million in 2024, and OMEX focus on specialty plant nutrition and biostimulant formulations. Atlántica Agrícola's Razormin contains vitamin complexes together with amino acids and polysaccharides, and OMEX's StimPro-K is labelled with vitamin B1 and vitamin C. Both sell through subsidiaries and distributors in more than 70 countries. Numerous regional formulators in India, China, Latin America and the Middle East also compete, mainly on price.
Competitor Dashboard
The competitor dashboard rates each company on four parameters relevant to the vitamin-based biostimulants market, based on an assessment of publicly available information on product portfolios, geographic footprint, partnerships and history in the biostimulant business.
Threat of New Entrants – Medium
Formulation of basic vitamin and amino acid blends requires modest capital, and many regional companies operate in emerging markets.
Registration requirements in the EU, India and, increasingly, Brazil raise entry costs through efficacy data, conformity assessment and quality standards.
Established players benefit from brand recognition, distribution networks and trial data built over many years.
Bargaining Power of Suppliers – Medium
Vitamin production is concentrated among a limited number of large producers, many of them in China, which gives suppliers some pricing power.
Vitamins and co-ingredients are standardised commodities available from several sources, and vitamins usually account for a small part of total formulation cost.
Integrated companies that process their own seaweed or run fermentation reduce dependence on external suppliers.
Bargaining Power of Buyers – Medium
Large distributors, cooperatives and commercial growers can negotiate on price and switch between brands.
Smallholders buy in small volumes and rely on dealer recommendations, which limits their individual bargaining power.
Product differentiation based on proven efficacy and agronomic support reduces price sensitivity for premium brands.
Threat of Substitutes – High
Growers can choose other biostimulant classes, such as seaweed extracts, amino acids and protein hydrolysates, humic substances and microbial products, for similar stress-mitigation or quality goals.
Conventional foliar fertilisers, micronutrients and plant growth regulators are alternatives for some yield and quality objectives.
Improved crop genetics, irrigation and agronomic practices can reduce the perceived need for biostimulant treatments.
Intensity of Competitive Rivalry – High
The market includes large multinational groups and many regional formulators, which leads to strong competition on price and claims.
Product differentiation is difficult because many formulations combine similar ingredients.
Companies compete through acquisitions, distribution agreements, new launches and investment in trial data.
Threat of new entrants: Medium; Low capital needs offset by rising registration requirements.
Bargaining power of suppliers: Medium; Concentrated vitamin production, but small share of formulation cost.
Bargaining power of buyers: Medium; Large distributors negotiate; smallholders depend on dealer advice.
Threat of substitutes: High; Wide range of alternative biostimulant classes and foliar nutrients.
Intensity of competitive rivalry: High; Fragmented market with similar formulations and active M&A.
Market estimates by geography (2032)
InsightEurope leads with $805.29M by 2032, while Asia Pacific is projected to grow fastest at a 10.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $201.21M | $299.48M | $446.33M | 8.3% | 19% |
| Europe | $375.21M | $548.80M | $805.29M | 7.9% | 34% |
| Asia Pacific | $202.18M | $344.63M | $571.49M | 10.9% | 24% |
| Latin America | $147.75M | $249.62M | $410.91M | 10.8% | 17% |
| Middle East & Africa | $45.69M | $77.68M | $127.52M | 10.8% | 5% |
| Total | $972.04M | $1.52B | $2.36B | 9.3% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$2.36B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Liquid | $1.71B | 9.9% | 72% |
| Dry | $651.79M | 7.9% | 28% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Vitamin-Based Biostimulants Market covering market dynamics, competitive landscape, and strategic outlook.
The Vitamin-Based Biostimulants Market market is projected to reach $2.36B by 2032, growing at 9.3% CAGR. The Liquid segment holds the largest share.
The Global Vitamin-Based Biostimulants Market is shaped by agronomic, regulatory and economic factors. Climate-driven abiotic stress, the shift toward lower-input and more efficient crop nutrition, and the expansion of high-value horticulture support demand. Variable field results, registration costs and raw material volatility constrain growth. This chapter assesses these factors and the trends and challenges expected to influence the market during 2026–2032.
Market Growth Factor Analysis
The table below sets out five macro and five micro factors that influence the market, the direction of their impact and an impact score out of 10 for three forecast windows. The impact scores are analyst assessments based on secondary research and discussions with industry participants; a higher score indicates a stronger influence on market growth in that period.
Rising Incidence of Abiotic Stress on Crops
Heat waves, drought, irregular rainfall and soil salinity are reducing crop yields and quality in major producing regions, including southern Europe, India, northern China, the Middle East, Mexico and parts of South America. Abiotic stress causes the build-up of reactive oxygen species in plant tissue, damaging membranes, photosynthetic systems and reproductive organs. Vitamins such as ascorbic acid, tocopherols, thiamine and folic acid are part of the plant's own antioxidant and metabolic defence, and exogenous application, usually combined with osmoprotectants such as glycine betaine and proline, is used to help crops maintain photosynthesis, flowering and fruit set during stress periods. Products such as Valagro's MEGAFOL, Biolchim's FOLICIST and HaifaStim Promo are positioned specifically as anti-stress or recovery treatments. Because growers apply these products in response to forecast or observed stress events, more frequent extreme weather translates directly into more application occasions per season. Abiotic-stress tolerance is also one of the claim categories recognised for plant biostimulants under Regulation (EU) 2019/1009, which gives manufacturers a defined basis for marketing stress-mitigation benefits.
Regulatory Recognition of Plant Biostimulants
Biostimulants are moving from a loosely regulated product group into defined legal categories. In the European Union, Regulation (EU) 2019/1009 has applied since 16 July 2022 and created product function category PFC 6 for plant biostimulants, which can be CE-marked and sold across the single market after conformity assessment. In India, an amendment to the Fertiliser (Control) Order notified in February 2021 brought biostimulants under Schedule VI and listed vitamins as one of the recognised biostimulant categories; provisional registrations ended in June 2025, and products now require notification under Schedule VI. Brazil enacted its Bioinputs Law (Law No. 15.070) in December 2024, covering growth stimulants, and in the United States the Plant Biostimulant Act was introduced in Congress in 2025, with its provisions carried into Farm Bill legislation passed by the House of Representatives in April 2026. Clearer rules raise entry requirements but give credible manufacturers a stable route to market, improve grower confidence and encourage investment in product development and efficacy trials.
Expansion of High-Value Horticulture and Quality-Driven Production
Fruits and vegetables generate much higher revenue per hectare than field crops, and their market value depends heavily on size, colour, firmness, sugar content and shelf life. Export-oriented producers in Spain, Italy, Mexico, Chile, Peru, Morocco, India and China must meet strict retailer specifications and residue limits, which favours inputs that improve quality without adding chemical residues. Protected cultivation in greenhouses and net houses, which is expanding in Spain, China, Mexico, Turkey and the Gulf states, relies on fertigation and frequent foliar programmes that easily accommodate biostimulant applications. Vitamin-based products are commonly included in programmes around transplanting, flowering and fruit set. This is reflected in the market data, where Fruits & Vegetables accounted for 55.0% of global revenue in 2025.
Focus on Nutrient-Use Efficiency and Input Costs
The sharp rise in fertiliser prices in 2021–2022 and continuing price volatility have increased growers' interest in getting more yield from each unit of nutrient applied. Biostimulants are marketed to improve nutrient uptake and assimilation, and improving nutrient-use efficiency is one of the claims recognised for biostimulants in the EU. Policy goals in several regions to cut nutrient losses to water and air, and environmental limits on nitrogen use in intensive farming areas, reinforce this trend. Fertiliser companies such as Haifa Group and OMEX increasingly sell biostimulants alongside their nutrient products as part of crop programmes, which gives vitamin-containing formulations access to established fertiliser distribution channels and to growers already using fertigation and foliar feeding.
Formalisation of the Indian Biostimulant Market
India's move from provisional registrations to notified Schedule VI products is shrinking the number of products on the market and rewarding companies with efficacy data and compliant formulations. Because vitamins are a recognised biostimulant category, registered vitamin-based products can gain share in a market projected to grow from USD 50.38 million in 2025 to USD 120.01 million in 2032, the fastest growth among the countries covered.
Adoption in Cereals and Broadacre Crops
Stress-mitigation products have so far been used mainly in horticulture, but their use on wheat, maize, rice and other cereals is increasing as growers seek protection against heat and drought at flowering and grain fill. Cereals & Grains is the fastest-growing crop segment, at a CAGR of 10.41%, and low-dose foliar products that can be tank-mixed with herbicides, fungicides or foliar nutrients provide a cost-effective entry point for large-area crops.
Bioinput Policies and Protected Agriculture in Emerging Regions
Brazil's Bioinputs Law and national programmes supporting biological inputs, together with rapid growth of protected agriculture and fertigation in the Gulf states, North Africa and Asia, create room for vitamin-based biostimulants in fertigation and seed-applied programmes. Latin America is projected to grow at 10.52% and Middle East & Africa at 10.41% over 2026–2032, above the global average of 9.22%.
Variable Field Efficacy and Limited Grower Awareness
Responses to vitamin-based biostimulants vary with crop, growth stage, timing, dose and weather, and benefits are often most visible under stress conditions. In seasons without significant stress, growers may not see a measurable yield return, which makes repeat purchases uncertain. Many smallholders in emerging markets lack access to agronomic advice and demonstration trials, and past sales of products with unproven claims have damaged trust in parts of the category, particularly in India, where thousands of provisional registrations were cancelled in June 2025.
Regulatory Fragmentation and Compliance Costs
Registration requirements differ widely between and within regions. The EU requires CE-marking with notified-body assessment; the United States has no federal definition and relies on state fertiliser laws and EPA guidance on plant regulator claims; India requires Schedule VI notification and efficacy data; and Brazil's bioinputs decree is still being finalised. Generating multi-location efficacy and safety data for each market raises costs, especially for small and medium-sized formulators, and lengthens time to market.
Raw Material Price Volatility and Formulation Stability
Global vitamin production is concentrated among a small number of producers, a large share of which are located in China, which exposes formulators to price swings and supply interruptions. Several vitamins, notably ascorbic acid and some B vitamins, are sensitive to heat, light, oxygen and pH, which complicates formulation, increases packaging and stabilisation costs and limits shelf life, particularly in hot climates.
Challenge: Demonstrating Return on Investment to Growers
Growers need consistent, quantified evidence of yield or quality benefits to justify recurring spending. Building local trial data, training distributor agronomists and integrating products into digital crop-advisory tools that time applications to stress forecasts remain important for wider adoption.
Trend: Multi-Component and Fermentation-Derived Formulations
Manufacturers increasingly combine vitamins with amino acids, betaines, seaweed extracts and micronutrients in a single product so that each component addresses a different part of the stress response. Fermentation-derived ingredients are also gaining ground; Tradecorp's Biimore, launched in 2022, is produced by fermenting molasses and contains L-amino acids, vitamins and sugars, and Rovensa opened a pilot fermentation plant in Brazil in 2026.
Trend: Consolidation and Entry of Large Crop-Input Groups
Large crop-protection and fertiliser companies have acquired biostimulant specialists to build biologicals platforms, including Syngenta's integration of Valagro into Syngenta Biologicals, Corteva's acquisitions of Stoller and Symborg, J.M. Huber's acquisition of the Biolchim Group and Rovensa's purchase of Cosmocel. These groups bring global distribution and regulatory resources, accelerating market access for specialist products.
Trend: Science-Based Claims and Standardisation
CEN Technical Committee 455 has developed the EN 17700 series of standards on plant biostimulant claims, and Japan's Ministry of Agriculture, Forestry and Fisheries issued labelling guidelines for biostimulants in May 2025. Manufacturers are investing in multi-site trials and mode-of-action research to substantiate claims for nutrient-use efficiency, stress tolerance and quality.
The value chain for vitamin-based biostimulants runs from the supply of vitamins and co-ingredients through formulation and manufacturing to distribution and use on farms.
Raw materials and inputs: vitamins such as thiamine, riboflavin, folic acid, ascorbic acid and tocopherols are produced by chemical synthesis or fermentation by specialty chemical and nutrition ingredient manufacturers. Co-ingredients include amino acids and protein hydrolysates, glycine betaine, seaweed extracts (for example Ascophyllum nodosum and Ecklonia maxima), plant extracts, molasses-based fermentation products, chelated micronutrients, carriers, stabilisers and adjuvants.
Formulation and manufacturing: biostimulant companies blend actives into liquid concentrates, suspensions, soluble powders or granules. Key capabilities include protecting vitamins from degradation, ensuring compatibility in tank mixes, quality control of active content and generating efficacy data for registration. Several companies operate their own seaweed or fermentation processing, while others source ingredients from specialised suppliers or use contract manufacturers.
Distribution and channels: products reach growers through national and regional agri-input distributors, retail dealer networks, farmer cooperatives, fertigation and irrigation solution providers and direct sales to large commercial growers. Large crop-protection companies sell biostimulants through their existing crop-protection channels, and online agri-input platforms are emerging as a channel in India and other markets.
End users: commercial fruit and vegetable growers, greenhouse operators, cereal and grain farmers, and growers of other crops such as oilseeds, pulses, plantation crops, turf and ornamentals. Agronomists, crop advisers and cooperatives strongly influence product selection and application timing.
European Union
Regulation (EU) 2019/1009 on EU fertilising products has applied since 16 July 2022. It defines plant biostimulants by function and creates product function category PFC 6, divided into microbial (PFC 6(A)) and non-microbial (PFC 6(B)) biostimulants. Products must be made from permitted component material categories, meet limits on contaminants and undergo conformity assessment by a notified body before CE-marking. Manufacturers may continue to sell non-CE-marked products under national rules. CEN/TC 455 has developed the EN 17700 series of standards supporting biostimulant claims, and Regulation (EU) 2024/2516 introduces digital labelling provisions that apply from 1 May 2027.
North America
In the United States there is no federal legal definition of a plant biostimulant. Products are regulated as fertilisers or soil amendments under state laws, while products that make plant regulator claims fall under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). FIFRA excludes nutrient mixtures and products known as vitamin-hormone horticultural products that are non-toxic and not intended for pest control from the plant regulator definition. The EPA issued draft guidance on plant regulator claims, including plant biostimulants, in 2019 and an updated draft in 2020. AAPFCO approved a model Uniform Beneficial Substances Bill in February 2024, and California added definitions of beneficial substances and plant biostimulants to its Food and Agricultural Code through SB 1522 in 2024. The Plant Biostimulant Act (H.R. 3783 and S. 1907) was introduced in 2025. In Canada, biostimulants are regulated as supplements under the Fertilizers Act and Fertilizers Regulations administered by the Canadian Food Inspection Agency; amended regulations took effect in October 2020 with a transition period that ended in October 2023.
Asia Pacific
India brought biostimulants under the Fertiliser (Control) Order, 1985 through a notification of 23 February 2021, which introduced Schedule VI and listed categories that include vitamins. Provisional registrations were extended several times and ended on 16 June 2025, after which only products notified in Schedule VI may be sold; further amendments in 2025 and 2026 added specifications, testing methods and designated laboratories. In China, fertiliser products must be registered with or filed with the Ministry of Agriculture and Rural Affairs under the Fertilizer Registration Management Measures, and industry standards such as NY 1429-2010 (amino acid water-soluble fertilisers) and NY/T 3831-2021 (organic water-soluble fertilisers) cover many biostimulant-type products. Japan's Ministry of Agriculture, Forestry and Fisheries published guidelines on the labelling of biostimulants in May 2025, while fertilisers remain subject to the Fertilizer Quality Act.
Latin America
Brazil's Law No. 15.070 of 23 December 2024 (the Bioinputs Law) covers biofertilisers, inoculants and growth stimulants, requires registration of commercial products and allows on-farm production for own use; its implementing decree was under preparation by the Ministry of Agriculture and Livestock (MAPA) in 2026. Fertilisers, inoculants and stimulants are also regulated under Decree 4.954/2004, which was amended by Decree 12.858 of February 2026. Other Latin American countries generally regulate biostimulants within fertiliser registration systems.
Middle East & Africa
In South Africa, fertilisers are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act (Act 36 of 1947), administered by the Registrar within the Department of Agriculture. In most Middle Eastern and African countries biostimulants are registered under general fertiliser or agricultural input regulations rather than a dedicated biostimulant category.
Mar 2022: Haifa Group; Acquisition; Acquired control of its Ecuadorian distributor Horticoop Andina, renamed Haifa Ecuador.
May 2022: Rovensa; Acquisition; Agreed to acquire Cosmocel, a Mexican specialty biostimulant, nutrition and adjuvant company.
May 2022: UPL (NPP); Partnership; Formed a strategic partnership with Kimitec's MAAVi Innovation Center to bring biostimulant and nutrition products to North America.
Jun 2022: Rovensa (Tradecorp); Product launch; Launched Biimore worldwide, a fermentation-derived biostimulant containing L-amino acids, vitamins and sugars.
Nov 2022: J.M. Huber Corporation; Acquisition; Completed the acquisition of the Biolchim Group, including Cifo, Ilsa, Matécsa and West Coast Marine-Bio Processing.
Nov 2022: Corteva Agriscience; Acquisition; Signed an agreement to acquire Stoller Group for USD 1.2 billion.
Jan 2023: UPL (NPP); Product launch; Launched the WAVE seaweed-based biostimulant in Canada after CFIA registration.
Feb 2023: Rovensa; Business expansion; Launched Rovensa Next as a global biosolutions business unit.
Mar 2023: Corteva Agriscience; Acquisition; Completed the acquisitions of Stoller and Symborg to form Corteva Biologicals.
Jul 2023: Syngenta Group; Business expansion; Brought Valagro and its in-house biologicals business together under the Syngenta Biologicals brand.
Nov 2023: Rovensa; Acquisition; Acquired Agro-K, a US specialty nutrition and biostimulant company.
Feb 2025: Syngenta Group; Partnership; Partnered with Ceres Biotics to expand global access to the VIXERAN biostimulant.
Feb 2025: Syngenta Group; Acquisition; Acquired Novartis's repository of natural compounds and strains for agricultural use.
Apr 2025: OMEX; Certification; Kelpak seaweed biostimulant obtained CE-marking under Regulation (EU) 2019/1009.
May 2025: Syngenta Group; Expansion; Opened a biologicals manufacturing plant in Orangeburg, South Carolina, United States.
Oct 2025: Gowan Company; Acquisition; Acquired Ceradis, a Netherlands-based formulation and biological technology company.
Oct 2025: Atlántica Agrícola; Expansion; Announced its 2025–2030 strategic plan to double the business, with expansion in Brazil, Turkey and the USA.
Dec 2025: Rovensa (Rovensa Next); Product launch; Launched Myndra, a biostimulant for fruit quality in woody perennial crops, in Europe.
Feb 2026: Rovensa (Rovensa Next); Expansion; Opened a pilot fermentation plant in Brazil.
Apr 2026: Haifa Group; Partnership; Joined the European Biostimulants Industry Council (EBIC).
May 2026: Syngenta Group; Acquisition; Acquired Intrinsyx Bio, a developer of nutrient-use-efficiency biologicals.
May 2026: UPL (NPP); Registration; Obtained Fertiliser (Control) Order registration in India for the Bioclassic biostimulant.
Sep 2026: UPL; Investment; UPL Corp Japan acquired a stake in PhytoChrome Co., a Japanese biostimulant and fertiliser company.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 106 companies operating in the Vitamin-Based Biostimulants Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
Company Headquarters: Indianapolis, US Founded: 1989 Workforce: ~21,100 Company Working: Corteva Agriscience develops, manufactures, and markets a wide range of products, including seeds and traits, crop protection, software, and digital solutions, seed treatments, forages, inoculants, vegetation management, pasture management, turf and ornamental, urban pest management, and oil. It is directly present in more than 50 countries and covers all major regions such as North America, Asia-Pacific, Latin America, Europe, and the Middle East & Africa. Corteva Agriscience is a subsidiary of Dow Chemical Company. Hence, the provided financial information is of the Dow Chemical Company.
4 interactive charts drawn from the Vitamin-Based Biostimulants Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Vitamin-Based Biostimulants Market By Application Method
Global Vitamin-Based Biostimulants Market By Crop Type
Global Vitamin-Based Biostimulants Market By Physical Form
Global Vitamin-Based Biostimulants Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
